← Leaderboards
Peter M. Hobart
Vical, Inc.
$2,818,910
Attributed
$2,818,910
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,818,910 · 4
By mechanism
R44$1,923,739 · 1
R41$462,918 · 1
R43$432,253 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vector Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,587,333
- Louis J. Picker · Oregon Health And Science University$70,366,260
- David Heimbrook · Leidos Biomedical Research, Inc.$68,561,099
Research focus
Vector VaccinePlasmidsVaccine DevelopmentLaboratory MouseActive ImmunizationBioterrorism /Chemical WarfareAnthraxAnthrax VaccinesBacillus AnthracisBacterial ToxinsDrug Screening /EvaluationGene Delivery SystemLaboratory RabbitLethal GenesNonhuman Therapy EvaluationSporesColony Stimulating FactorDrug Administration RoutesAntibody Neutralization TestTechnology /Technique DevelopmentHuman SubjectHuman Therapy EvaluationHumoral ImmunityHybrid Antibody